Your browser doesn't support javascript.
loading
AV-optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross-over study.
Zupan Meznar, Anja; Mrak, Miha; Mullens, Wilfried; Stublar, Jernej; Ivanovski, Maja; Zizek, David.
Afiliação
  • Zupan Meznar A; Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Mrak M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Mullens W; Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Stublar J; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Ivanovski M; Faculty of Medicine and Life Sciences, University Hasselt, Hasselt, Belgium.
  • Zizek D; Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia.
J Cardiovasc Electrophysiol ; 35(7): 1340-1350, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38686618
ABSTRACT

BACKGROUND:

Severe first-degree atrioventricular (AV) block may produce symptoms similar to heart failure due to AV dyssynchrony, a syndrome termed AV dromotropathy. According to guidelines, it should be considered for permanent pacemaker implantation, yet evidence supporting this treatment is scarce.

OBJECTIVES:

This study aimed to determine the impact of AV-optimized conduction system pacing (CSP) in patients with symptomatic severe first-degree AV block and echocardiographic signs of AV dyssynchrony.

METHODS:

Patients with symptomatic first-degree AV block (PR > 250 ms), preserved left ventricular ejection fraction, narrow QRS, and AV dyssynchrony were included in the study. In a single-blind cross-over design, patients were randomized to AV sequential CSP or backup VVI pacing with a base rate of 40 bpm. We compared exercise capacity, echocardiographic parameters, and symptom occurrence at the end of 3 months of each period.

RESULTS:

Fourteen patients completed the study. During the AV-optimized CSP compared to the backup pacing period, patients achieved a higher workload on exercise test (147.2 ± 50.9 vs. 140.7 ± 55.8 W; p = .032), with a trend towards higher peak VO2 (23.3 ± 7.1 vs. 22.8 ± 7.1 mL/min/kg; p = .224), and higher left ventricular stroke volume (LVSV 74.5 ± 13.8 vs. 66.4 ± 12.5 mL; p < .001). Symptomatic improvement was recorded, with fewer patients reporting general tiredness and 71% of patients preferring the AV-optimized CSP (p = .008).

CONCLUSIONS:

AV-optimized CSP could improve symptoms, exercise capacity and LVSV in patients with severe first-degree AV block.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estimulação Cardíaca Artificial / Função Ventricular Esquerda / Tolerância ao Exercício / Estudos Cross-Over / Bloqueio Atrioventricular / Frequência Cardíaca Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Electrophysiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estimulação Cardíaca Artificial / Função Ventricular Esquerda / Tolerância ao Exercício / Estudos Cross-Over / Bloqueio Atrioventricular / Frequência Cardíaca Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Electrophysiol Ano de publicação: 2024 Tipo de documento: Article